BRCA Mutations in Women With Inflammatory Breast Cancer

Cancer - United States
doi 10.1002/cncr.31069
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Trends in Breast MRI Use Among Women With BRCA Mutations: A National Claims Analysis 2006–2016

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

BRCAness Combined With Family History of Cancer Is Associated With Poor Prognosis in Breast Cancer Patients With High Risk of BRCA Mutations

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Long-Term Results of Screening With Magnetic Resonance Imaging in Women With BRCA Mutations

British Journal of Cancer
Cancer ResearchOncology
2012English

The Impact of Reproductive Life on Breast Cancer Risk in Women With Family History or BRCA Mutation

Oncotarget
Oncology
2016English

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer

Oncotarget
Oncology
2017English

The Value of BRCA 1 Gene Mutation in Patients With Breast Cancer

Sohag Medical Journal
2018English

Breast Cancer Phenotype in Women With TP53 Germline Mutations: A Li-Fraumeni Syndrome Consortium Effort

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy